AUXL Share Price

Open 36.50 Change Price %
High 36.76 1 Day -0.06 -0.16
Low 36.08 1 Week 0.00 0.00
Close 36.47 1 Month 0.00 0.00
Volume 3714961 1 Year 0.00 0.00
52 Week High 6.35
52 Week Low 3.66
AUXL Important Levels
Resistance 2 37.10
Resistance 1 36.84
Pivot 36.44
Support 1 36.10
Support 2 35.84
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL)

AUXL Technical Analysis 4
As on 29th Jan 2015 AUXL Share Price closed @ 36.47 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 26.98 & Buy for SHORT-TERM with Stoploss of 34.54 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUXL Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
AUXL Other Details
Segment EQ
Market Capital 986353600.00
Sector Healthcare
Industry Drug Related Products
Offical website http://www.auxilium.com
AUXL Address
AUXL
640 Lee Road
Chesterbrook, PA 19087
United States
Phone: 484-321-5900
Fax: 484-321-5999
Interactive Technical Analysis Chart Auxilium Pharmaceuticals, Inc. ( AUXL NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Auxilium Pharmaceuticals, Inc.
AUXL Business Profile
Auxilium Pharmaceuticals, Inc., incorporated on July 23, 1999, is a specialty biopharmaceutical company. The Company focuses on developing and marketing products to predominantly specialist audiences. It market two products: Testim testosterone gel and XIAFLEX (collagenase clostridium histolyticum). XIAFLEX is an injectable clostridial collagenase enzyme approved by the United States Food and Drug Administration (FDA) for the treatment of Dupuytren's contracture (Dupuytren's) in adult patients with a palpable cord. The Company’s Testim is a topical 1% testosterone once-a-day gel that treats hypogonadism by restoring normal testosterone blood levels for a 24-hour period following application and sustaining them in that range when used daily. In April 2013, the Company acquired Actient Holdings LLC. Testim has been approved for marketing for the indication of male hypogonadism in the United States, Canada, Belgium, Denmark, Finland, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden and the United Kingdom. XIAFLEX offers medical treatment option for physicians and patients who desire a minimally invasive alternative to surgery. The Company’s XIAFLEX is used for the treatment of Adhesive Capsulitis and edematous fibrosclerotic panniculopathy. BioSpecifics Technologies Corporation (BioSpecifics), from whom the Company has licensed worldwide rights to develop, market and sell certain products containing the collagenase enzyme, has conducted a Phase II clinical trial using CCH for the treatment of Frozen Shoulder syndrome.